Barbara Graham
About
Barbara Graham is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research.
According to data from OpenAlex, Barbara Graham has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Barbara Graham's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Cancer Treatment and Pharmacology (5 papers). Barbara Graham is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Cancer Treatment and Pharmacology (5 papers). Barbara Graham collaborates with scholars based in Canada, United States and India. Barbara Graham's co-authors include Frances A. Shepherd, Lesley Seymour, Keyue Ding, David H. Johnson, Marlo Whitehead, Robert B. Livingston, Timothy Winton, James R. Rigas, Glenwood Goss and Tim Winton and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and The Journal of Pediatrics.
In The Last Decade
Barbara Graham
19 papers receiving 1.0k citations
Peers
Barbara Graham
H. Le Caer France
Shimao Fukai Japan
Takatoshi Fujishita Japan
Noriaki Sakakura Japan
I. Maestu Spain
H Cüneyt Ulutin Türkiye
Linda Coate Ireland
Puja Venkat United States
Christelle Clément-Duchêne France
N. Bayman United Kingdom
Citations per year, relative to Barbara Graham Barbara Graham (= 1×)
peers
H. Le Caer
Countries citing papers authored by Barbara Graham
Since
Specialization
Citations
This map shows the geographic impact of Barbara Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Graham more than expected).
Fields of papers citing papers by Barbara Graham
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Barbara Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Graham. The network helps show where Barbara Graham may publish in the future.
Co-authorship network of co-authors of Barbara Graham
This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Graham. A scholar is included among the top collaborators of Barbara Graham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Graham. Barbara Graham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Renouf, Daniel J., Neesha C. Dhani, Petr Kavan, et al.. (2018). The Canadian Cancer Trials Group PA.7 trial: Results from the safety run in of a randomized phase II study of gemcitabine (GEM) and nab-paclitaxel (Nab-P) versus GEM, nab-P, durvalumab (D), and tremelimumab (T) as first-line therapy in metastatic pancreatic ductal adenocarcinoma (mPDAC).. Journal of Clinical Oncology. 36(4_suppl). 349–349.
2.
Renouf, Daniel J., Petr Kavan, Neesha C. Dhani, et al.. (2017). The CCTG PA.7 trial: A randomized phase II study of gemcitabine and nab-paclitaxel vs. gemcitabine, nab-paclitaxel, durvalumab, and tremelimumab as 1st line therapy in metastatic pancreatic ductal adenocarcinoma (PDAC).. Journal of Clinical Oncology. 35(15_suppl). TPS4149–TPS4149.
3.
Reaume, M. Neil, Natasha B. Leighl, Nicole Mittmann, et al.. (2013). Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial). Lung Cancer. 82(1). 115–120.
4.
Bramwell, V., Kathleen I. Pritchard, Dongsheng Tu, et al.. (2009). A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada—Clinical Trials Group Trial, MA.12). Annals of Oncology. 21(2). 283–290.
5.
Vincent, Mark, Charles Butts, Lesley Seymour, et al.. (2009). Updated survival analysis of JBR.10: A randomized phase III trial of vinorelbine/cisplatin versus observation in completely resected stage IB and II non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 27(15_suppl). 7501–7501.
6.
Butts, Charles, Keyue Ding, Lesley Seymour, et al.. (2009). Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10. Journal of Clinical Oncology. 28(1). 29–34.
7.
Bezjak, Andrea, Christopher W. Lee, Keyue Ding, et al.. (2008). Quality-of-Life Outcomes for Adjuvant Chemotherapy in Early-Stage Non–Small-Cell Lung Cancer: Results From a Randomized Trial, JBR.10. Journal of Clinical Oncology. 26(31). 5052–5059.
8.
Bezjak, Andrea, Keyue Ding, T. Winton, et al.. (2007). Quality of life (QOL) impact of adjuvant chemotherapy for early stage non-small cell lung cancer (NSCLC): Final analysis of JBR.10 randomized trial. Journal of Clinical Oncology. 25(18_suppl). 7585–7585.
9.
Pepe, Carmela, Baktiar Hasan, Timothy Winton, et al.. (2007). Adjuvant Vinorelbine and Cisplatin in Elderly Patients: National Cancer Institute of Canada and Intergroup Study JBR.10. Journal of Clinical Oncology. 25(12). 1553–1561.
10.
Asmis, Timothy R., Keyue Ding, Lesley Seymour, et al.. (2007). Age and Comorbidity As Independent Prognostic Factors in the Treatment of Non–Small-Cell Lung Cancer: A Review of National Cancer Institute of Canada Clinical Trials Group Trials. Journal of Clinical Oncology. 26(1). 54–59.
11.
Bramwell, V., Kathleen I. Pritchard, Dongsheng Tu, et al.. (2007). Tamoxifen (T) compared to placebo (P), after adjuvant chemotherapy (CT), in premenopausal women with early breast cancer (EBC): Interim results of NCIC-CTG MA.12. Journal of Clinical Oncology. 25(18_suppl). 547–547.
12.
Gauthier, L., Keyue Ding, T. Winton, et al.. (2006). Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: The JBR.10 trial experience. Lung Cancer. 55(3). 357–363.
13.
Alam, Naveed, Frances A. Shepherd, Timothy Winton, et al.. (2005). Corrigendum to: “Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer: An analysis of National Cancer institute of Canada and intergroup trial JBR.10 and a review of the literature” [Lung Cancer 47 (2005) 385–394]. Lung Cancer. 50(2). 283–284.
14.
Gauthier, L., Keyue Ding, T. Winton, et al.. (2005). P-615 Do hemoglobin (Hb) levels influence outcomes of adjuvant chemotherapy (ACT) with cisplatin/vinorelbine in patients (pts) with completely resected non small cell lung cancer (NSCLC)? The JBR.10 trial experience. Lung Cancer. 49. S280–S280.
15.
Alam, Naveed, Frances A. Shepherd, Timothy Winton, et al.. (2004). Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. Lung Cancer. 47(3). 385–394.
16.
Birch, Robert, et al.. (2004). Randomized phase IIb trial comparing two schedules of docetaxel (D) plus estramustine (E) for metastatic hormone refractory prostate cancer (HRPC). Journal of Clinical Oncology. 22(14_suppl). 4622–4622.
17.
Birch, Robert, et al.. (2004). Randomized phase IIb trial comparing two schedules of docetaxel (D) plus estramustine (E) for metastatic hormone refractory prostate cancer (HRPC). Journal of Clinical Oncology. 22(14_suppl). 4622–4622.
18.
Winton, Tim, Keyue Ding, Barbara Graham, et al.. (2003). O-58 Quality of life in a trial of adjuvant chemotherapy for early stage completely resected non-small cell lung cancer (NCIC CTG BR.10). Lung Cancer. 41. S20–S20.
19.
Hartmann, Alexis F., et al.. (1973). Measurement of blood pressure in the brachial and posterior tibial arteries using the Doppler method. The Journal of Pediatrics. 82(3). 498–500.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by H. Le Caer Breakdown of academic impact, for papers by Shimao Fukai Breakdown of academic impact, for papers by Takatoshi Fujishita Breakdown of academic impact, for papers by Noriaki Sakakura Breakdown of academic impact, for papers by I. Maestu Breakdown of academic impact, for papers by H Cüneyt Ulutin Breakdown of academic impact, for papers by Linda Coate Breakdown of academic impact, for papers by Puja Venkat Breakdown of academic impact, for papers by Christelle Clément-Duchêne Breakdown of academic impact, for papers by N. Bayman